Barbara Martin-Manzanares

Cordoba, AN 14071, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Immune Modulation Through KIR-HLA Interactions Influences Cetuximab Efficacy in Colorectal Cancer.

Immune Modulation Through KIR-HLA Interactions Influences Cetuximab Efficacy in Colorectal Cancer.

Journal: International journal of molecular sciences
Published: June 23, 2025

Dynamics of NK cell subsets following autologous hematopoietic stem cell transplantation in adult oncologic patients.

Dynamics of NK cell subsets following autologous hematopoietic stem cell transplantation in adult oncologic patients.

Journal: Frontiers in immunology
Published: May 15, 2025

Natural killer cells adopt an activated and decidual-like phenotype after autologous hematopoietic stem cell transplantation in children with cancer.

Natural killer cells adopt an activated and decidual-like phenotype after autologous hematopoietic stem cell transplantation in children with cancer.

Journal: Communications medicine
Published: April 03, 2024

Genetic Polymorphisms of GGH and ABCC2 Are Associated with Methotrexate Intolerance in Patients with Rheumatoid Arthritis.

Genetic Polymorphisms of GGH and ABCC2 Are Associated with Methotrexate Intolerance in Patients with Rheumatoid Arthritis.

Journal: Journal of clinical medicine
Published: August 16, 2021

Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes.

Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes.

Journal: Journal for immunotherapy of cancer
Published: March 06, 2021

Evolution after switching to biosimilar infliximab in inflammatory bowel disease patients in clinical remission.

Evolution after switching to biosimilar infliximab in inflammatory bowel disease patients in clinical remission.

Journal: Gastroenterologia y hepatologia
Published: April 26, 2017

HLA-B, HLA-C and KIR improve the predictive value of IFNL3 for Hepatitis C spontaneous clearance.

HLA-B, HLA-C and KIR improve the predictive value of IFNL3 for Hepatitis C spontaneous clearance.

Journal: Scientific reports
Published: April 20, 2017

HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients.

HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients.

Journal: The pharmacogenomics journal
Published: October 26, 2016

KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors.

KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors.

Journal: Frontiers in immunology
Published: September 29, 2016

KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.

KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.

Journal: The pharmacogenomics journal
Published: October 27, 2015

HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy.

HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy.

Journal: The pharmacogenomics journal
Published: October 20, 2015

Natural killer KIR3DS1 is closely associated with HCV viral clearance and sustained virological response in HIV/HCV patients.

Natural killer KIR3DS1 is closely associated with HCV viral clearance and sustained virological response in HIV/HCV patients.

Journal: PloS one
Published: September 10, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026